Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

240.48
-0.8300-0.34%
Post-market: 240.480.00000.00%16:15 EDT
Volume:1.03M
Turnover:248.56M
Market Cap:15.61B
PE:16.44
High:244.46
Open:240.94
Low:239.29
Close:241.31
52wk High:266.38
52wk Low:123.88
Shares:64.91M
Float Shares:62.69M
Volume Ratio:1.79
T/O Rate:1.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.25
PE(LYR):-41.18

Loading ...

May 02, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2024

Major Issues Report

Form 8-K - Current report
Apr 26, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mar 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 27, 2024

Major Issues Report

Form 8-K - Current report
Feb 21, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 25, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Sep 12, 2023

Major Issues Report

Form 8-K - Current report
Sep 12, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Sep 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities